… Bone lesions can cause pain, disability, and skeletal events, as well as deteriorates quality
… discusses the theragnostic radionuclide pairs for PCa management and radionuclide therapy …

… Bone lesions can cause pain, disability, and skeletal events, as well as deteriorates quality
… discusses the theragnostic radionuclide pairs for PCa management and radionuclide therapy …

… can be used in lieu of 64Cu for radionuclide therapy. This paper briefly discusses the production,
and clinical applications of 64Cu/67Cu … theragnostic duos and therapeutic radionuclides…

… the management of castrate-resistant prostate cancer (PCa). … by the optimal theranostic
radionuclide pairs to be applied in … in clinical practice, in recent years the duo 64 Cu/ 67 Cu has …

… Prostate cancer (PCa) is considered the most frequent tumor … The treatment of prostate
carcinoma is impeded by the late … In this regard, it would be of interest to use a PET radionuclide …

… theranostic compounds. In some states, different training requirements exist for using imaging
tracers versus therapeutic radionuclides [26]. … for administration in a hot lab and can be …

… result in the first treatment specifically targeting prostate cancer using these … Theragnostic
radionuclide pairs for prostate cancer management: 64Cu/67Cu, can be a budding hot duo…

… potential ones and can also be used for theragnostic applications [… So, duo the special physical
characteristics of 64 Cu, this … applications, and other radionuclides may compete with it in …

… both diagnosis and treatment, but with different radionuclides, this is known as a theranostic
pair. … Novel diagnostic tracers like 64Cu/67Cu have longer half-lives and are currently being …